At CTO East Coast, experts reflected on designing oncology clinical trials for success and how to account for a shifting geopolitical landscape in the US.

It’s an interesting study, to be sure — if only the headlines actually described it. Turns out, only about 6 percent of the ...

There isn't a one-size-fits-all treatment for perimenopause symptoms, but you can start by tackling your most bothersome ...

As cryptocurrency theft grows increasingly sophisticated, we at CryoGuards have developed specialized crypto recovery ...

Look, I used to be that person cramming protein powder into everything, wondering why I still felt like garbage despite […] ...

Background: Subclinical hypothyroidism has been linked to adverse renal outcomes, but it is unknown whether treatment of subclinical hypothyroidism reduces the risk of these adverse outcomes. We ...

Increasing patient demand, barriers to access, and elevated costs are pushing healthcare providers to reconsider traditional ...

That’s important as we move into an era of new interfaces, where we’re not just limited to typing to our AI partners. We have voice now, and more is coming in the future, with image and video ...

Introduction The past decade has witnessed significant advancements in genome-targeted oncology drugs within the realm of precision medicine (PM). However, the cost-effectiveness of oncology PM in a ...

Are you preparing for UPSC CSE 2025? Here are questions from GS paper 2 for this week with essential points as the fodder for ...

A year after launch, AI visualization tool Napkin has attracted over five million users by keeping things fun.